Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasma cell | 14 studies | 34% ± 13% | |
B cell | 10 studies | 24% ± 9% | |
ciliated cell | 10 studies | 26% ± 9% | |
IgG plasma cell | 6 studies | 22% ± 7% | |
naive B cell | 5 studies | 21% ± 3% | |
pro-B cell | 4 studies | 32% ± 7% | |
plasmablast | 4 studies | 42% ± 12% | |
IgA plasma cell | 4 studies | 26% ± 14% | |
memory B cell | 4 studies | 21% ± 2% | |
hepatocyte | 4 studies | 36% ± 14% | |
epithelial cell | 3 studies | 24% ± 5% | |
endothelial cell | 3 studies | 18% ± 1% |
Insufficient scRNA-seq data for expression of TP53INP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 5203.28 | 245 / 245 | 100% | 112.02 | 502 / 502 |
breast | 100% | 3252.33 | 457 / 459 | 99% | 78.32 | 1104 / 1118 |
liver | 100% | 11243.46 | 226 / 226 | 98% | 88.26 | 399 / 406 |
thymus | 100% | 3177.15 | 652 / 653 | 98% | 39.07 | 595 / 605 |
kidney | 100% | 2497.81 | 89 / 89 | 97% | 38.71 | 876 / 901 |
pancreas | 100% | 9787.29 | 328 / 328 | 96% | 26.75 | 170 / 178 |
lung | 100% | 7218.86 | 577 / 578 | 95% | 39.36 | 1097 / 1155 |
esophagus | 100% | 3255.28 | 1444 / 1445 | 91% | 23.52 | 166 / 183 |
bladder | 100% | 2855.81 | 21 / 21 | 90% | 26.07 | 452 / 504 |
uterus | 100% | 3597.94 | 170 / 170 | 89% | 22.91 | 410 / 459 |
ovary | 99% | 2511.93 | 178 / 180 | 87% | 20.52 | 372 / 430 |
adrenal gland | 98% | 3014.94 | 253 / 258 | 85% | 18.22 | 195 / 230 |
skin | 99% | 3275.61 | 1786 / 1809 | 81% | 22.77 | 382 / 472 |
stomach | 99% | 3340.42 | 357 / 359 | 72% | 15.09 | 207 / 286 |
intestine | 100% | 4890.57 | 962 / 966 | 67% | 12.70 | 355 / 527 |
brain | 52% | 556.15 | 1374 / 2642 | 93% | 23.28 | 656 / 705 |
spleen | 100% | 11793.90 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.00 | 1 / 1 |
blood vessel | 99% | 3326.82 | 1327 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 3243.55 | 1194 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 34.36 | 28 / 29 |
peripheral blood | 93% | 4014.79 | 861 / 929 | 0% | 0 | 0 / 0 |
heart | 92% | 1616.79 | 790 / 861 | 0% | 0 | 0 / 0 |
muscle | 87% | 1476.36 | 698 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 25.43 | 39 / 45 |
eye | 0% | 0 | 0 / 0 | 44% | 9.26 | 35 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0009408 | Biological process | response to heat |
GO_0098869 | Biological process | cellular oxidant detoxification |
GO_0048147 | Biological process | negative regulation of fibroblast proliferation |
GO_0071447 | Biological process | cellular response to hydroperoxide |
GO_1904761 | Biological process | negative regulation of myofibroblast differentiation |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0034644 | Biological process | cellular response to UV |
GO_0000045 | Biological process | autophagosome assembly |
GO_0071361 | Biological process | cellular response to ethanol |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0048102 | Biological process | autophagic cell death |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_0006915 | Biological process | apoptotic process |
GO_0072703 | Biological process | cellular response to methyl methanesulfonate |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0016605 | Cellular component | PML body |
GO_0005776 | Cellular component | autophagosome |
GO_0005634 | Cellular component | nucleus |
GO_0016209 | Molecular function | antioxidant activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TP53INP1 |
Protein name | Tumor protein p53-inducible nuclear protein 1 (Stress-induced protein) (p53-dependent damage-inducible nuclear protein 1) (p53DINP1) |
Synonyms | P53DINP1 SIP |
Description | FUNCTION: Antiproliferative and proapoptotic protein involved in cell stress response which acts as a dual regulator of transcription and autophagy. Acts as a positive regulator of autophagy. In response to cellular stress or activation of autophagy, relocates to autophagosomes where it interacts with autophagosome-associated proteins GABARAP, GABARAPL1/L2, MAP1LC3A/B/C and regulates autophagy. Acts as an antioxidant and plays a major role in p53/TP53-driven oxidative stress response. Possesses both a p53/TP53-independent intracellular reactive oxygen species (ROS) regulatory function and a p53/TP53-dependent transcription regulatory function. Positively regulates p53/TP53 and p73/TP73 and stimulates their capacity to induce apoptosis and regulate cell cycle. In response to double-strand DNA breaks, promotes p53/TP53 phosphorylation on 'Ser-46' and subsequent apoptosis. Acts as a tumor suppressor by inducing cell death by an autophagy and caspase-dependent mechanism. Can reduce cell migration by regulating the expression of SPARC. . |
Accessions | ENST00000342697.5 [Q96A56-1] Q96A56 ENST00000448464.6 [Q96A56-2] |